Once the patent is granted, it is expected to last through 2031, according to the report. The company plans to file for CE marking later this year. Clinical trials for FDA approval will be initiated in 2016.
More articles on gastroenterology:
7 things for gastroenterologists to know for today – April 24, 2015
4 GI physicians making headlines – April 24, 2015
Expanding services: The best ancillary lines for GI practices to consider in 2015
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
